Your liver uses the ATP7B gene to handle copper, an essential mineral, and remove the extra amount through bile. If both copies carry disease-causing variants, copper can build up in the liver, brain, and eyes and cause Wilson disease. People with Wilson disease may develop liver problems, shaking, stiffness, mood changes, or trouble with movement, although symptoms vary. Genetic testing of the ATP7B gene can help confirm this diagnosis.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for building proteins, the parts of cells that do much of the work. Other genes mostly control when certain processes happen, where they happen, and how strongly they are carried out. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. To go deeper into this topic, you can find more in the LearnHub.
Overview
ATP7BGene function
What if the gene works
The ATP7B gene helps the liver move extra copper into bile so it can leave the body. It also helps place copper onto proteins that carry it in the blood.
Risk
What if the gene does not work
Variants in the ATP7B gene can cause Wilson disease, with copper buildup in the liver and brain. Milder to more severe variants may change when problems begin and whether liver, movement, mood, or thinking changes are more noticeable.
Treatment
What does that mean for your treatment
A pathogenic variant in the ATP7B gene supports standard copper lowering treatment, usually with a chelator such as penicillamine or trientine, or with zinc to reduce copper absorption. Drug choice is guided mainly by symptoms, age, and liver or neurologic involvement, not by the exact ATP7B variant. Liver transplant can help when liver damage is advanced.
Conditions associated with ATP7B
Gene function
What if the gene works
Copper from food is useful in small amounts, so your body needs a careful way to move it, use it, and clear what is extra. In liver cells, the ATP7B gene is central to this balance. Understanding how the ATP7B gene handles copper in the liver helps explain how your body keeps this mineral at healthy levels.
The ATP7B gene provides instructions for a protein that uses energy to move copper to the right place inside liver cells. This careful transport is a basic part of normal copper balance.
In the liver, the ATP7B protein moves extra copper into bile, the digestive fluid made by the liver. This lets the body remove surplus copper through the intestines.
ATP7B also adds copper to ceruloplasmin, a blood protein that carries copper through the body. This helps make copper available to tissues in a controlled way.
Liver cells can shift where the ATP7B protein works depending on how much copper is present. This helps the body adjust smoothly to normal day to day changes in copper intake.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant changes how a gene functions more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
ATP7B gene variants can alter the protein's shape, stability, or ability to move copper, which helps explain how ATP7B gene variants affect copper handling in cells. Some changes misfold the protein so it is broken down early or stuck in the wrong part of the cell, while others reduce but do not fully remove activity. Milder variants may leave partial function, but more severe variants can leave very little ATP7B activity and are often linked to earlier or more noticeable Wilson disease features.
How variants are linked to conditions
The link between variants in the ATP7B gene and Wilson disease is well established. People usually need two disease-causing variants, one from each parent, for the condition to develop or for genetic testing to confirm the diagnosis. Wilson disease can affect the liver, nervous system, and mental health. People carrying one variant in the ATP7B gene usually do not develop the condition.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant connected with a condition indicates a possible association rather than a definite diagnosis, particularly when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Your chance of having ATP7B-related Wilson disease mainly depends on whether you inherit harmful changes in both copies of the ATP7B gene; having an affected sibling or parents who are blood relatives can raise that chance. Once those changes are present, there is not enough evidence that lifestyle changes prevent the condition, but early diagnosis and avoiding extra copper can help limit complications.
Inheritance of ATP7B variants
ATP7B gene inheritance for Wilson disease follows an autosomal recessive pattern. This means a person usually inherits one ATP7B variant from each parent before the condition develops. If both parents carry one variant, each pregnancy has a 25% chance of resulting in a child with Wilson disease, a 50% chance of a child who is a carrier, and a 25% chance of a child with no variant in the ATP7B gene. Parents who are carriers usually do not have the condition themselves.
What does my ATP7B result mean for my family?
For families with an ATP7B result linked to Wilson disease, close relatives may also carry the same gene change, and some may have the condition even if they feel well. Brothers and sisters are often the relatives most likely to share the same result. Parents are usually healthy carriers, and other relatives may also be carriers. Family testing can help clarify who may need follow-up.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the ATP7B gene usually uses a blood or saliva sample. A lab reads the ATP7B gene’s DNA code to look for changes linked to Wilson disease. Results can help confirm the diagnosis or show whether someone carries a familial variant.
When should I consider getting a genetic test?
Consider ATP7B genetic testing if you or your child have signs of Wilson disease, a condition where copper builds up in the body, or if routine tests show unexplained liver problems, movement changes, or abnormal copper blood tests. Testing is also often considered when a close relative has Wilson disease.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but the amount they reveal varies with the condition and the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug may work well for one person, have little effect in another, or cause more side effects in someone else. Part of the difference comes from how each body absorbs, breaks down, transports, and clears a medicine, and these inherited differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect a person’s response to medications. By looking at relationships between genes and drugs, it helps clarify why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the ATP7B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices. For medication side effects, treatment changes, or general health concerns, it is best to talk with your doctor. ATP7B has been studied in cancer research because it may affect how cells handle some platinum-based chemotherapy drugs, but this is not used routinely in everyday care.
History
Throughout history, people described families in which copper built up in the body and led to liver and movement problems, long before the cause was clear. In 1912, Samuel Alexander Kinnier Wilson gave the condition a fuller medical description, linking these features into what became known as Wilson disease. Inheritance patterns were noticed long before the gene was identified. Building on this early work, scientists mapped the responsible region to chromosome 13 in the late 1980s, and in 1993 researchers identified the ATP7B gene. That discovery helped confirm why the condition runs in families and opened the way for more precise genetic testing. Over time, descriptions became more precise, and the ATP7B gene became a key part of the modern story of inherited copper overload.